Publications by authors named "Thomas Goedecke"

Claim this Profile
D
Duration of Time Intervals for Risk Minimization Measure Effectiveness Studies.
Sharon C M Essink, Inge M Zomerdijk, Thomas Goedecke, Sabine M J M Straus, Helga Gardarsdottir

Clin Pharmacol Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limitations Reported in Evaluating Effectiveness of Risk Minimization Measures in the EU during 2018-2021: A Qualitative Analysis of Industry-Sponsored Post-Authorization Safety Studies.
Renske J Grupstra, Thomas Goedecke, Helga Gardarsdottir

Clin Pharmacol Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations.
Thomas Goedecke, Liana Martirosyan, Nathalie Gault, Karin Seifert, Daniel R Morales

Pharmacoepidemiol Drug Saf· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of Studies Evaluating Effectiveness of Risk Minimization Measures Assessed by the European Medicines Agency Between 2016 and 2021.
Renske J Grupstra, Thomas Goedecke, Jet Scheffers, Valerie Strassmann, Helga Gardarsdottir

Clin Pharmacol Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ENCePP Code of Conduct: A best practise for scientific independence and transparency in noninterventional postauthorisation studies.
Rosa Gini, Xavier Fournie, Helen Dolk, Xavier Kurz, Patrice Verpillat, Thomas Goedecke

Pharmacoepidemiol Drug Saf· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilance.
Victoria Newbould, Steven Le Meur, Thomas Goedecke, Xavier Kurz

Drug Saf· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to 'Comment on 'Measuring the impact of medicines regulatory interventions - systematic review and methodological considerations' by Goedecke et al.'.
Thomas Goedecke, Daniel R Morales, Alexandra Pacurariu, Xavier Kurz

Br J Clin Pharmacol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation.
Alexandra Pacurariu, Kelly Plueschke, Patricia McGettigan, Daniel R Morales, Jim Slattery, Thomas Goedecke

BMJ Open· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.
Thomas Goedecke, Daniel R Morales, Alexandra Pacurariu, Xavier Kurz

Br J Clin Pharmacol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilance.
Victoria Newbould, Steven Le Meur, Thomas Goedecke, Xavier Kurz

Drug Saf· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilance.
Victoria Newbould, Steven Le Meur, Thomas Goedecke, Xavier Kurz

Drug Saf· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error Prevention.
Thomas Goedecke, Kathryn Ord, Victoria Newbould, Sabine Brosch, Peter Arlett

Drug Saf· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis